Skip to content
DataLookout
Menu

ECA-AANCT06297967

Acetic Acid 2% Solution for Skin Ulcers

StatusRecruiting
PhasePhase 3
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Mar 2027 to Mar 2028
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 6 of 8 entries
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 2025 to Apr 27, 2025
    • Site details revised
    v6
  3. Notable Start date: Sep 2024 to Mar 2025
    • Primary and study completion dates: Sep 2026 to Mar 2027
    • Site contact updated
    v5
  4. Minor Secondary endpoints: 6 to 8v4
  5. Notable Start date: Apr 2024 to Sep 2024
    • Primary and study completion dates pushed to Sep 2026
    v3
  6. Minor Secondary endpoints revised (6)v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change in ulcer area compared to baseline (percentage) at 8 weeks of treatment
Timeframe: 8 weeks

Secondary (8)

Percentage of participants with ulcer healing at 4 weeks from the start of treatment.
Percentage of participants with ulcer healing at 12 weeks from the start of treatment.
Time (days) to ulcer healing from the start of treatment.
Changes in the wound bed at 8 weeks according to score of section 6 of the RESVECH2.0 ("Expected Results of the Assessment and Evaluation of Healing of Chronic Wounds" scale.
Number of adverse reactions associated with the treatment, collected from the medical record.
Show 3 moreShow less
The healthcare expenditure associated with each branch of the study
Change in ulcer area compared to baseline (percentage) at 4 weeks of treatment
Change in ulcer area compared to baseline (percentage) at 12 weeks of treatment

Arms and interventions

Acetic AcidExperimental

Topic application of a Acetic Acid 2% solution for 15 min, typically administered every 24h. The frequency of the treatments may be modified according to the evolution of the lesion at the discretion of the nurse in charge of the treatments

Control groupActive comparator

Topic application of Prontosan® for 15 min, typically administered every 24h. The frequency of the treatments may be modified according to the evolution of the lesion at the discretion of the nurse in charge of the treatments

Drugs: Acetic Acid, Prontosan

Sites

1 site in 1 country

  • Consorci Sanitari Alt'Pènedes i GarrafBarcelona, Catalonia, Spain